Supplementary Table 2

Comparison of rheumatic/autoimmune diseases (RAD) and B27 frequency in male patients with hypogonadism (MPHG) and in controls (general population in Mexico City)

Condition

RAD/HGMP

(%)

RAD/controls

(%)

OR

95% CI

P^a

RAD/no RAD

8/5

(61)

368/43445^b

(0.83)

188.89

55.9–665.91

<0.001

Ankylosing spondylitis

4/9

(30.7)

5/43832^b

(0.01)

2697.4

531.6–13586.8

<0.001

Systemic lupus erythematosus

2/11

(15.3)

15/43822^b

(0.03)

449.5

0–2391.1

<0.001

Polymyositis/dermatomyositis

1/12

(7.6)

18/43837^b

(0.04)

187.2

-

0.006

Juvenile rheumatoid arthritis

1/12

(7.6)

14/43823^b

(0.03)

-

-

0.004

Rheumatoid arthritis

0/13

(0)

272/43565^b

(0.62)

0.0

0–63.7

0.9

Other RAD^*

0/13

(0)

44/43793^b

(0.1)

0.0

0–407.1

0.9

B27 (+)/(-)

4/9

(30.7)

27/638^c

(4)

7.27

1.86–26.2

0.005

B27 = histocompatibility antigen B27; CI = confidence interval; OR = odds ratio; - = not calculable. ^aFisher exact test. ^bReference [32]. ^cReference [33]. ^*Other RAD = Sjogren's syndrome, mix connective tissue disease, scleroderma, rheumatic fever, reactive arthritis etc.

Jimenez-Balderas et al. Arthritis Res 2001 3:362   doi:10.1186/ar328